106 related articles for article (PubMed ID: 25677667)
1. Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors.
Neubert T; Numa M; Ernst J; Clemens J; Krenitsky P; Liu M; Fleck B; Woody L; Zuccola H; Stamos D
Bioorg Med Chem Lett; 2015 Mar; 25(6):1338-42. PubMed ID: 25677667
[TBL] [Abstract][Full Text] [Related]
2. Fragment-based discovery of hydroxy-indazole-carboxamides as novel small molecule inhibitors of Hsp90.
Buchstaller HP; Eggenweiler HM; Sirrenberg C; Grädler U; Musil D; Hoppe E; Zimmermann A; Schwartz H; März J; Bomke J; Wegener A; Wolf M
Bioorg Med Chem Lett; 2012 Jul; 22(13):4396-403. PubMed ID: 22632933
[TBL] [Abstract][Full Text] [Related]
3. Design and SAR of macrocyclic Hsp90 inhibitors with increased metabolic stability and potent cell-proliferation activity.
Zapf CW; Bloom JD; McBean JL; Dushin RG; Nittoli T; Ingalls C; Sutherland AG; Sonye JP; Eid CN; Golas J; Liu H; Boschelli F; Hu Y; Vogan E; Levin JI
Bioorg Med Chem Lett; 2011 Apr; 21(8):2278-82. PubMed ID: 21420297
[TBL] [Abstract][Full Text] [Related]
4. Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone.
Vallée F; Carrez C; Pilorge F; Dupuy A; Parent A; Bertin L; Thompson F; Ferrari P; Fassy F; Lamberton A; Thomas A; Arrebola R; Guerif S; Rohaut A; Certal V; Ruxer JM; Gouyon T; Delorme C; Jouanen A; Dumas J; Grépin C; Combeau C; Goulaouic H; Dereu N; Mikol V; Mailliet P; Minoux H
J Med Chem; 2011 Oct; 54(20):7206-19. PubMed ID: 21972823
[TBL] [Abstract][Full Text] [Related]
5. Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.
Gopalsamy A; Shi M; Golas J; Vogan E; Jacob J; Johnson M; Lee F; Nilakantan R; Petersen R; Svenson K; Chopra R; Tam MS; Wen Y; Ellingboe J; Arndt K; Boschelli F
J Med Chem; 2008 Feb; 51(3):373-5. PubMed ID: 18197612
[TBL] [Abstract][Full Text] [Related]
6. Inside the Hsp90 inhibitors binding mode through induced fit docking.
Lauria A; Ippolito M; Almerico AM
J Mol Graph Model; 2009 Feb; 27(6):712-22. PubMed ID: 19084447
[TBL] [Abstract][Full Text] [Related]
7. Novel, potent small-molecule inhibitors of the molecular chaperone Hsp90 discovered through structure-based design.
Dymock BW; Barril X; Brough PA; Cansfield JE; Massey A; McDonald E; Hubbard RE; Surgenor A; Roughley SD; Webb P; Workman P; Wright L; Drysdale MJ
J Med Chem; 2005 Jun; 48(13):4212-5. PubMed ID: 15974572
[TBL] [Abstract][Full Text] [Related]
8. 3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperone.
Brough PA; Barril X; Beswick M; Dymock BW; Drysdale MJ; Wright L; Grant K; Massey A; Surgenor A; Workman P
Bioorg Med Chem Lett; 2005 Dec; 15(23):5197-201. PubMed ID: 16213716
[TBL] [Abstract][Full Text] [Related]
9. Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (hsp90) molecular chaperone.
Kung PP; Huang B; Zhang G; Zhou JZ; Wang J; Digits JA; Skaptason J; Yamazaki S; Neul D; Zientek M; Elleraas J; Mehta P; Yin MJ; Hickey MJ; Gajiwala KS; Rodgers C; Davies JF; Gehring MR
J Med Chem; 2010 Jan; 53(1):499-503. PubMed ID: 19908836
[TBL] [Abstract][Full Text] [Related]
10. Targeting the hydrophobic region of Hsp90's ATP binding pocket with novel 1,3,5-triazines.
Lee T; Seo YH
Bioorg Med Chem Lett; 2013 Dec; 23(23):6427-31. PubMed ID: 24125885
[TBL] [Abstract][Full Text] [Related]
11. Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors.
Casale E; Amboldi N; Brasca MG; Caronni D; Colombo N; Dalvit C; Felder ER; Fogliatto G; Galvani A; Isacchi A; Polucci P; Riceputi L; Sola F; Visco C; Zuccotto F; Casuscelli F
Bioorg Med Chem; 2014 Aug; 22(15):4135-50. PubMed ID: 24980703
[TBL] [Abstract][Full Text] [Related]
12. Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone.
Kung PP; Funk L; Meng J; Collins M; Zhou JZ; Johnson MC; Ekker A; Wang J; Mehta P; Yin MJ; Rodgers C; Davies JF; Bayman E; Smeal T; Maegley KA; Gehring MR
Bioorg Med Chem Lett; 2008 Dec; 18(23):6273-8. PubMed ID: 18929486
[TBL] [Abstract][Full Text] [Related]
13. N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors.
Bruncko M; Tahir SK; Song X; Chen J; Ding H; Huth JR; Jin S; Judge RA; Madar DJ; Park CH; Park CM; Petros AM; Tse C; Rosenberg SH; Elmore SW
Bioorg Med Chem Lett; 2010 Dec; 20(24):7503-6. PubMed ID: 21106457
[TBL] [Abstract][Full Text] [Related]
14. Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9.
Londregan AT; Aspnes G; Limberakis C; Loria PM; McClure KF; Petersen DN; Raymer B; Ruggeri RB; Wei L; Xiao J; Piotrowski DW
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3685-3688. PubMed ID: 30482620
[TBL] [Abstract][Full Text] [Related]
15. Structure insights into mechanisms of ATP hydrolysis and the activation of human heat-shock protein 90.
Li J; Sun L; Xu C; Yu F; Zhou H; Zhao Y; Zhang J; Cai J; Mao C; Tang L; Xu Y; He J
Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):300-6. PubMed ID: 22318716
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model.
Zapf CW; Bloom JD; Li Z; Dushin RG; Nittoli T; Otteng M; Nikitenko A; Golas JM; Liu H; Lucas J; Boschelli F; Vogan E; Olland A; Johnson M; Levin JI
Bioorg Med Chem Lett; 2011 Aug; 21(15):4602-7. PubMed ID: 21715165
[TBL] [Abstract][Full Text] [Related]
17. Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90).
Brasca MG; Mantegani S; Amboldi N; Bindi S; Caronni D; Casale E; Ceccarelli W; Colombo N; De Ponti A; Donati D; Ermoli A; Fachin G; Felder ER; Ferguson RD; Fiorelli C; Guanci M; Isacchi A; Pesenti E; Polucci P; Riceputi L; Sola F; Visco C; Zuccotto F; Fogliatto G
Bioorg Med Chem; 2013 Nov; 21(22):7047-63. PubMed ID: 24100158
[TBL] [Abstract][Full Text] [Related]
18. Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90.
Barta TE; Veal JM; Rice JW; Partridge JM; Fadden RP; Ma W; Jenks M; Geng L; Hanson GJ; Huang KH; Barabasz AF; Foley BE; Otto J; Hall SE
Bioorg Med Chem Lett; 2008 Jun; 18(12):3517-21. PubMed ID: 18511277
[TBL] [Abstract][Full Text] [Related]
19. Binding of ATP to heat shock protein 90: evidence for an ATP-binding site in the C-terminal domain.
Garnier C; Lafitte D; Tsvetkov PO; Barbier P; Leclerc-Devin J; Millot JM; Briand C; Makarov AA; Catelli MG; Peyrot V
J Biol Chem; 2002 Apr; 277(14):12208-14. PubMed ID: 11805114
[TBL] [Abstract][Full Text] [Related]
20. Targeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization.
Davies NG; Browne H; Davis B; Drysdale MJ; Foloppe N; Geoffrey S; Gibbons B; Hart T; Hubbard R; Jensen MR; Mansell H; Massey A; Matassova N; Moore JD; Murray J; Pratt R; Ray S; Robertson A; Roughley SD; Schoepfer J; Scriven K; Simmonite H; Stokes S; Surgenor A; Webb P; Wood M; Wright L; Brough P
Bioorg Med Chem; 2012 Nov; 20(22):6770-89. PubMed ID: 23018093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
